+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Native Bacterial and Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type, Pathogen Type; Application, End User, and Geography- Product Image
Native Bacterial and Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type, Pathogen Type; Application, End User, and Geography- Product Image
Sale

Native Bacterial and Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type, Pathogen Type; Application, End User, and Geography

  • PDF Icon

    Report

  • 179 Pages
  • September 2020
  • Region: Global
  • The Insight Partners
  • ID: 5178543
UP TO OFF until Jun 30th 2024
Description Jump to:

The market for Chlamydia Antigens to Grow at Fastest CAGR during 2020-2027

According to this new market research study on “Native Bacterial and Viral Antigens Market to 2027 - Global Analysis and Forecast - by Product Type, Pathogen Type, Application, and End User,” the market is expected to reach US$ 28,801.15 thousand by 2027 from US$ 17,105.05 thousand in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The report highlights trends prevailing in the global native bacterial and viral antigens market, and the drivers and restraints pertaining to the market growth.

On the basis of product type, the native bacterial and viral antigens market is segmented into chlamydia antigens, adenovirus antigens, borrelia antigens, clostridium antigens, chikungunya virus antigens, and dengue virus antigens. The chlamydia antigens segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period. Growth of the market for this segment is attributed to the easy availability of these antigens, with the majority of the market players commercially offering these antigens in the native forms.

The global native bacterial and viral antigens market growth is mainly attributed to factors such as increasing use of native microbial antigens in diagnostics and therapeutics and rising prevalence of infectious diseases. However, limitations associated with native antigens such as high cost, low antigen production levels, and scale-up difficulties may hinder the market growth.

BIO-RAD LABORATORIES INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd, Enzo Life Sciences Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company, Creative Diagnostics, and TRINA BIOREACTIVES AG is among the leading companies operating in the native bacterial and viral antigens market.

The Report Segments Global Native Bacterial and Viral Antigens Markets Follows:

By Product Type


  • Chlamydia Antigens
  • Adenovirus Antigens
  • Borrelia Antigens
  • Chikungunya Virus Antigens
  • Clostridium Antigens
  • Dengue Virus Antigens

By Product Type


  • Inactivated Pathogen
  • Purified Pathogen

By Application


  • ELISA
  • Immunoassay
  • SDS-PAGE
  • Hemagglutination
  • Agglutination Test

By End-User


  • Diagnostic Laboratories and Centers
  • Academic and Research Institutes

By Geography

North America


  • US
  • Canada
  • Mexico

Europe


  • France
  • Germany
  • UK
  • Spain
  • Italy

Asia Pacific (APAC)


  • China
  • India
  • Japan
  • Australia
  • South Korea

Middle East and Africa (MEA)


  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina

Reasons to Buy


  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the native bacterial and viral antigens market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global native bacterial and viral antigens market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Native Bacterial and Viral Antigens Market - By Product Type
1.3.2 Global Native Bacterial and Viral Antigens Market - By Pathogen Type
1.3.3 Global Native Bacterial and Viral Antigens Market - By Application
1.3.4 Global Native Bacterial and Viral Antigens Market - By End User
1.3.5 Global Native Bacterial and Viral Antigens Market - By Geography
2. Native Bacterial and Viral Antigens Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Native Bacterial and Viral Antigens Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Native Bacterial and Viral Antigens Market- Key Market Dynamics
5.1.1 Increasing Use of Native Microbial Antigens in Diagnostics and Therapeutics
5.1.2 Rising Prevalence of Infectious Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Native Antigens such as High Cost, Low Antigen Production Levels, Scale-up Difficulties
5.3 Market Opportunities
5.3.1 Developments in Emerging Economies
5.4 Future Trend
5.4.1 Growing Focus on Immunization Programs
5.5 Impact Analysis
6. Native Bacterial and Viral Antigens Market - Global Analysis
6.1 Global Native Bacterial and Viral Antigens Market Revenue Forecast and Analysis
6.2 Global Native Bacterial and Viral Antigens Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Native Bacterial and Viral Antigens Market Analysis - By Product Type
7.1 Overview
7.2 Native Bacterial and Viral Antigens Market Revenue Share, by Product Type (2019 and 2027)
7.3 Chlamydia Antigens
7.3.1 Overview
7.3.2 Chlamydia Antigens: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
7.4 Adenovirus Antigens
7.4.1 Overview
7.4.2 Adenovirus Antigens: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
7.5 Borrelia Antigens
7.5.1 Overview
7.5.2 Borrelia Antigens: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
7.6 Chikungunya Virus Antigens
7.6.1 Overview
7.6.2 Chikungunya Virus Antigens: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
7.7 Clostridium Antigens
7.7.1 Overview
7.7.2 Clostridium Antigens: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
7.8 Dengue Virus Antigens
7.8.1 Overview
7.8.2 Dengue Virus Antigens: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
8. Native Bacterial and Viral Antigens Market Analysis - By Pathogen Type
8.1 Overview
8.2 Native Bacterial and Viral Antigens Market Revenue Share, by Pathogen Type (2019 and 2027)
8.3 Inactivated Pathogen
8.3.1 Overview
8.3.2 Inactivated Pathogen: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
8.4 Purified Pathogen
8.4.1 Overview
8.4.2 Purified Pathogen: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
9. Native Bacterial and Viral Antigens Market Analysis - By Application
9.1 Overview
9.2 Native Bacterial and Viral Antigens Market Revenue Share, by Application (2019 and 2027)
9.3 ELISA
9.3.1 Overview
9.3.2 ELISA: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
9.4 Immunoassay
9.4.1 Overview
9.4.2 Immunoassay: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
9.5 SDS-PAGE
9.5.1 Overview
9.5.2 SDS-PAGE: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
9.6 Hemagglutination
9.6.1 Overview
9.6.2 Hemagglutination: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
9.7 Agglutination Test
9.7.1 Overview
9.7.2 Agglutination Test: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
10. Native Bacterial and Viral Antigens Market Analysis - By End User
10.1 Overview
10.2 Native Bacterial and Viral Antigens Market Revenue Share, by End User (2019 and 2027)
10.3 Diagnostic Laboratories and Centers
10.3.1 Overview
10.3.2 Diagnostic Laboratories and Centers: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
10.4 Academic and Research Institutes
10.4.1 Overview
10.4.2 Academic and Research Institutes: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (US$ Thousand)
11. Native Bacterial and Viral Antigens Market Analysis and Forecasts To 2027 Geographical Analysis
11.1 North America: Native Bacterial and Viral Antigens Market
11.1.1 Overview
11.1.2 North America: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.3 North America: Native Bacterial and Viral Antigens Market, by Product Type, 2018-2027 (USD Thousand)
11.1.4 North America: Native Bacterial and Viral Antigens Market, by Pathogen Type, 2018-2027 (USD Thousand)
11.1.5 North America: Native Bacterial and Viral Antigens Market, By Application, 2018-2027 (USD Thousand)
11.1.6 North America: Native Bacterial and Viral Antigens Market, By End User, 2018-2027 (USD Thousand)
11.1.7 North America: Native Bacterial and Viral Antigens Market, by Country, 2019 & 2027 (%)
11.1.8 US: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.8.1 US: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.8.2 US: Native Bacterial and Viral Antigens Market, by Product Type, 2018-2027 (USD Thousand)
11.1.8.3 US: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018-2027 (USD Thousand)
11.1.8.4 US: Native Bacterial and Viral Antigens Market, By Application, 2018-2027 (USD Thousand)
11.1.8.5 US: Native Bacterial and Viral Antigens Market, By End User, 2018-2027 (USD Thousand)
11.1.9 Canada: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.9.1 Canada: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.9.2 Canada: Native Bacterial and Viral Antigens Market, By Product Type, 2018-2027 (USD Thousand)
11.1.9.3 Canada: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018-2027 (USD Thousand)
11.1.9.4 Canada: Native Bacterial and Viral Antigens Market, By Application, 2018-2027 (USD Thousand)
11.1.9.5 Canada: Native Bacterial and Viral Antigens Market, By End User, 2018-2027 (USD Thousand)
11.1.10 Mexico: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.10.1 Mexico: Native Bacterial and Viral Antigens Market - Revenue and Forecast to 2027 (USD Thousand)
11.1.10.2 Mexico: Native Bacterial and Viral Antigens Market, By Product Type, 2018-2027 (USD Thousand)
11.1.10.3 Mexico: Native Bacterial and Viral Antigens Market, By Pathogen Type, 2018-2027 (USD Thousand)
11.1.10.4 Mexico: Native Bacterial and Viral Antigens Market, By Application, 2018-2027 (USD Thousand)
11.1.10.5 Mexico: Native Bacterial and Viral Antigens Market, By End User, 2018-2027 (USD Thousand)
11.2 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.2.1 Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.2 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.3 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.4 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.5 Europe Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.6 Europe Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.7.1 UK Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.7.2 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.7.3 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.7.4 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.7.5 UK Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.8 Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.8.1 Germany Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.8.2 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.8.3 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.8.4 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.8.5 Germany Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.9 France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.9.1 France Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.9.2 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.9.3 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.9.4 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.9.5 France Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.10 Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.10.1 Italy Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.10.2 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.10.3 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.10.4 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.10.5 Italy Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.2.11 Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.11.1 Spain Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.2.11.2 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.2.11.3 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.2.11.4 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.2.11.5 Spain Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.3 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.4 Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.1 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.2 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.3 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.4 Asia Pacific Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.5 Asia Pacific Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.4.6 Japan Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.6.1 Japan Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.6.2 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.6.3 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.6.4 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.6.5 Japan Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.7 China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.7.1 China Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.7.2 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.7.3 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.7.4 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.7.5 China Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.8 India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.8.1 India Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.8.2 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.8.3 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.8.4 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.8.5 India Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.9 South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.9.1 South Korea Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.9.2 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.9.3 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.9.4 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.9.5 South Korea Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.4.10 Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.10.1 Australia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.4.10.2 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.4.10.3 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.4.10.4 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.4.10.5 Australia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.5.1 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.2 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.3 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.4 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.5 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5.6 Middle East & Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.7.1 UAE Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.7.2 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.7.3 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.7.4 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.7.5 UAE Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5.8 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.8.1 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.8.2 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.8.3 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.8.4 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.8.5 Saudi Arabia Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.5.9 South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.9.1 South Africa Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.5.9.2 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.5.9.3 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.5.9.4 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.5.9.5 South Africa Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.6 South And Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts To 2027
11.6.1 South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.2 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.6.3 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.6.4 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.6.5 South and Central America Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.6.6 South and Central America Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027, By Country (%)
11.6.7 Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.7.1 Argentina Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.7.2 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.6.7.3 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.6.7.4 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.6.7.5 Argentina Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
11.6.8 Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.8.1 Brazil Native Bacterial and Viral Antigens Market Revenue and Forecasts to 2027 (US$ Thousand)
11.6.8.2 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Product Type (US$ Thousand)
11.6.8.3 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Pathogen Type (US$ Thousand)
11.6.8.4 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By Application (US$ Thousand)
11.6.8.5 Brazil Native Bacterial and Viral Antigens Market Revenue And Forecasts to 2027, By End User (US$ Thousand)
12. Impact of COVID-19 Pandemic on Global Anti-Viral Therapies Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of World: Impact Assessment of COVID-19 Pandemic
13. Native Bacterial and Viral Antigens Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 BIO-RAD LABORATORIES INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Microbix Biosystems
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 SERION Immunologics
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Aalto Bio Reagents Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Life Sciences, Inc.,
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Jena Bioscience GmbH
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 ROSS SOUTHERN LABORATORIES
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 The Native Antigen Company
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Creative Diagnostics
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 TRINA BIOREACTIVES AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BIO-RAD LABORATORIES INC.
  • Microbix Biosystems
  • SERION Immunologics
  • Aalto Bio Reagents Ltd
  • Enzo Life Sciences Inc.
  • Jena Bioscience GmbH
  • ROSS SOUTHERN LABORATORIES
  • The Native Antigen Company
  • Creative Diagnostics
  • TRINA BIOREACTIVES AG

Related Topics

Related Reports

Herpes Simplex Virus Treatment Market - Forecasts from 2024 to 2029 - Product Image

Herpes Simplex Virus Treatment Market - Forecasts from 2024 to 2029

  • Report
  • 140 Pages
  • Global
From
Anti-infective Research and Development: Updates on Infection Mechanisms and Treatments - Product Image

Anti-infective Research and Development: Updates on Infection Mechanisms and Treatments

  • Book
From
Anti-Infectives: Global Strategic Business Report - Product Image

Anti-Infectives: Global Strategic Business Report

  • Report
  • 116 Pages
  • Global
From
Viral, Parasitic, Bacterial, and Fungal Infections. Antimicrobial, Host Defense, and Therapeutic Strategies - Product Image

Viral, Parasitic, Bacterial, and Fungal Infections. Antimicrobial, Host Defense, and Therapeutic Strategies

  • Book
Hunter's Tropical Medicine and Emerging Infectious Diseases. Edition No. 10 - Product Image

Hunter's Tropical Medicine and Emerging Infectious Diseases. Edition No. 10

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.